Clinical Trial Update: Study of Alemtuzumab in Treatment Refractory MS Subjects/Alemtuzumab Naive & Alemtuzumab Experienced Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating alemtuzumab in treatment-refractory multiple sclerosis subjects as well as alemtuzumab-naive and alemtuzumab-experienced individuals; c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Alemtuzumab (Alemtuzumab)

Snippet

Sponsor: Samuel Forrester Hunter, MD, PhD | Conditions: Multiple Sclerosis | Phase 1 | Status: UNKNOWN